Brief: Quest Diagnostics Q3 Adjusted EPS USD 3 Vs. IBES Estimate USD 2.86
BRIEF-Quest Diagnostics Q3 Adjusted EPS USD 3 Vs. IBES Estimate USD 2.86 Oct 22 (Reuters) - Quest Diagnostics Q3 net income USD 312 million.
- Q3 revenue USD 3,097 million vs. IBES estimate USD 3,046 million
- Q3 EPS USD 2.78
- outlook FY EPS USD 10.21-10.31
- outlook FY adjusted EPS USD 11.25-11.35 vs. IBES estimate USD 11.2
- outlook FY revenue USD 12,065-12,105 million vs. IBES estimate USD 12,001 million
Recent news on Quest Diagnostics
See all newsUS RESEARCH ROUNDUP- Amgen, Lockheed Martin, Norfolk Southern
U.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Brief: Quest Diagnostics - Reports Unauthorized Access To Quanum Lsm System On Oct 21, 2026
Laboratory operator Quest reports cyber breach affecting patient records
Quest Diagnostics down after cyber incident disclosure